N.Z.’s Australo Develops Desktop, Quick Virus Counter
This article was originally published in PharmAsia News
A New Zealand device maker says it has developed a device, qViro, capable of counting the viruses in a sample within minutes. Other devices count viruses, but the qViro made by Australo is desk-top size compared with competitors as large as washing machines that require days to provide a result and cost five times as much. Australo expects to begin marketing its qViro in April. The device works by pulling single molecules through a "nanopore," and is capable of being adjusted to count particles of a particular size. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.